- Report
- August 2023
- 115 Pages
Global
From €2235EUR$2,250USD£1,858GBP
- Report
- September 2018
- 17 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Drug Pipelines
- August 2018
- 171 Pages
Global
From €21856EUR$22,000USD£18,172GBP
- Report
- July 2018
- 33 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- July 2018
- 30 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- July 2018
- 27 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- July 2018
- 41 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- February 2018
- 16 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- February 2018
- 23 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Drug Pipelines
- February 2018
- 16 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Drug Pipelines
- February 2018
- 16 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- February 2018
- 680 Pages
Global
From €21856EUR$22,000USD£18,172GBP
- Report
- March 2022
- 300 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- July 2023
- 260 Pages
Global
From €2434EUR$2,450USD£2,024GBP
- Report
- January 2023
- 125 Pages
Global
From €2474EUR$2,490USD£2,057GBP
- Report
- July 2021
- 35 Pages
Global
- Report
- February 2020
- 120 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- August 2023
- 8 Pages
United States
From €522EUR$525USD£434GBP
- Report
- January 2023
- 50 Pages
China
From €2980EUR$3,000USD£2,478GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more